Life Science

Più recente

281 a 290 di 518
  • Product infringing a Canadian patent insufficiently “illegal” to avoid an English cross undertaking to pay damages Accesso limitato

    Articolo

    Inviato: 03 May 2012

    Are damages payable under an English cross undertaking when the product concerned is manufactured in infringement of a foreign patent?

  • UK Patent Box Accesso limitato

    Articolo

    Inviato: 17 April 2012

    A brief overview of the UK’s forthcoming patent box regime and steps to be taken to prepare for its introduction.

  • France set to become tougher for medtech as elections loom Accesso limitato

    Articolo

    Inviato: 10 April 2012

    2012 is set to be a year full of important decisions impacting the French landscape, brought on by the climate of uncertainty resulting from recent healthcare product scandals. Alexandre Regniault reflects on the current climate and the impact of the latest French regulatory measures.

  • Crossborder injunctions - has the spider returned to its web? Accesso limitato

    Articolo

    Inviato: 03 April 2012

    Advocate General Cruz Villalón says in Solvay v Honeywell that “spider in the web” crossborder, interim injunctions are permissible in certain “nuanced” circumstances.

  • Neuer Gesetzesentwurf zur Regelung von Lizenzen in der Insolvenz Accesso limitato

    Articolo

    Inviato: 27 March 2012

    Es liegt ein neuer Gesetzesentwurf zur Behandlung von Lizenzverträgen in der Insolvenz vor. Damit sollen Lizenzen in der Insolvenz des Lizenzgebers stärker geschützt werden.

  • UK Budget 2012 - benefits for Life Sciences Accesso limitato

    Articolo

    Inviato: 23 March 2012

    The UK Government's Budget on 21 March 2012 contained a number of measures which should improve the competitiveness of the UK's corporation tax regime for pharmaceutical and biotech companies.

  • Teva stopped in their tracks Accesso limitato

    Articolo

    Inviato: 20 March 2012

    In an application brought in the High Court an injunction has been ordered against Teva’s launch of their generic efavirenz onto the UK market.

  • Insolvency and Intellectual Property Accesso limitato

    Articolo

    Inviato: 14 March 2012

    An examination of insolvency and intellectual property considerations in Europe.

  • European patent litigation – structure and developments Accesso limitato

    Articolo

    Inviato: 20 February 2012

    Progress towards a unified patent system in Europe is moving fast, but for the time being the complex differences in national patent regimes persist. This article examines those differences and the implications for those starting or defending a patent infringement claim. This article forms part of our Unified Patent Court Toolkit.

  • 欧州における特許訴訟-その構造と進展 Accesso limitato

    Articolo

    Inviato: 20 February 2012

    欧州では統一特許制度に向けた動きが加速していますが、当面は、各国ごとに異なる複雑な特許制度が欧州では存続することになります。本稿では、特許侵害を張する者又はされた者にとって、各国制度の違いがどのように影響するのかを整理します。

281 a 290 di 518